View All News

Teleflex Focuses on Innovative Infection Prevention Solutions at the Association for Professionals in Infection Control and Epidemology’s (APIC) 39th Annual Educational Conference & International Meeting

June 1, 2012

Products and education designed to help providers improve outcomes

LIMERICK, Pa.--(BUSINESS WIRE)--Jun. 1, 2012-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will showcase a number of anesthesia, respiratory therapy and vascular access products at the Association for Professionals in Infection Control and Epidemology's (APIC) 39th Annual Educational Conference & International MeetingJune 3-6, 2012 in San Antonio, Texas.

Teleflex will highlight:

  • Teleflex ISIS® HVT™ Endotracheal Tubes, which are comprehensive, convertible endotracheal tubes that provide optimal airway access and management. With an integrated suction port and separate suction line for subglottic secretion removal, the ISIS HVT tubes meet the needs of patients requiring both short- and long-term ventilation without the need to change tubes.
  • Softech® Plus Cannulas are a line of oxygen cannulas designed to help clinicians improve patient comfort and reduce DEHP exposure. The Softech Plus line of adult, pediatric, infant and neonatal oxygen cannulas feature a soft material in both the cannula and the lariat tubing, which runs from the nasal prongs up to, over and around the ear. Softer materials have traditionally only been used for the prongs. By expanding this soft material to the lariat, the design delivers a superior cannula which improves comfort around the patient's ears.
  • The Gibeck® Humid-Flo® 72-Hour Integrated Kit provides clinicians everything they need to start passive humidification and promote best practices to help reduce the risk of ventilator-associated pneumonia (VAP). 1-3

    The Gibeck Humid-Flo Heat & Moisture Exchanger (HME):
  • Enables all components to remain in-line during the first 72 hours of mechanical ventilation, even when aerosol treatments are given;
  • Reduces circuit breaks and allows for adherence to clinical practice guidelines1-3
  • Maximizes clinical outcomes by eliminating the need to interrupt ventilation, allowing positive end-expiratory pressure (PEEP) to be maintained.
  • The Arrow® ErgoPack™ System is an ergonomic packaging system for vascular access procedures designed to efficiently facilitate compliance with best practices, evidence-based medicine, guidelines and recommendations from organizations to reduce the risk of Central Line-Associated Bloodstream Infections (CLABSI).
  • The Arrow® PICC with Chlorag+ard® Technology is the only chlorhexidine-treated PICC. It provides broad-spectrum antimicrobial protection both intra- and extraluminally, for at least 30 days.4 Proven 99.99% colonization reduction against gram-positive and gram-negative bacteria and fungi, including pathogens such as MRSA, VRE, Escherichia coli, Candida albicans and Acinetobacter baumannii.4

In addition, Teleflex will offer:

  • Inbooth Education for attendees at Teleflex booth 712. Teleflex is proud to offer education in Airway Management, Respiratory Therapy, and Vascular Access. The Airway Management and Respiratory Therapy education will focus on the prevention of Ventilator Associated Pneumonia (VAP); the Vascular Access education will focus on vascular access device selection, catheter-related thrombosis, CLABSI prevention, and catheter malposition.

For more information on Teleflex's anesthesia, respiratory therapy and vascular access products, as well as its educational programs, visit teleflex.com.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,500 people worldwide and serves healthcare providers in more than 130 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, Arrow, Chlorag+ard, ErgoPack, Gibeck, Humid-Flo, HVT, ISIS, and Softech are trademarks or registered trademarks of Teleflex Incorporated or its affiliates. ©2012 Teleflex Incorporated. All rights reserved. 2012-0926

References:

  1. Coffin SE, Klompas M, Classen D, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29:S31-S40.
  2. Hess DR, Kallstrom TJ, Mottram CD, Myers TR, Sorenson HM, Vines DL; for the American Association for Respiratory Care. Care of the ventilator and its relation to ventilator-associated pneumonia. Respir Care. 2003;48:869-879.
  3. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R; for the CDC and the Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing healthcare-associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004;53(RR-3):1-36.
  4. In vitro data on file, Teleflex Incorporated.

Source: Teleflex Incorporated

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836

View All News